Evidence map›Paper›PMID 26131344›Full record

ArticleIranian journal of pediatric hematology and oncology2015

Association between height and malignancy among children in the north of Iran.

B Darbandi, A Baghersalimi, M Jafroodi, Z Atrkarroshan, S H Koohmanaei, A Hassanzadeh Rad, S Dalili

Abstract read

In one paragraph

Article in Iranian journal of pediatric hematology and oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

B DarbandiPediatric Growth Disorders Research Center, 17 Shahrivar Hospital, Guilan University of Medical Sciences, Rasht, Iran. ; Pediatric Hematologist/Oncologist, Guilan University of Medical Sciences, Rasht, Iran.

A BaghersalimiPediatric Growth Disorders Research Center, 17 Shahrivar Hospital, Guilan University of Medical Sciences, Rasht, Iran. ; Pediatric Hematologist/Oncologist, Guilan University of Medical Sciences, Rasht, Iran.

M JafroodiPediatric Growth Disorders Research Center, 17 Shahrivar Hospital, Guilan University of Medical Sciences, Rasht, Iran. ; Pediatric Hematologist/Oncologist, Guilan University of Medical Sciences, Rasht, Iran.

Z AtrkarroshanPediatric Growth Disorders Research Center, 17 Shahrivar Hospital, Guilan University of Medical Sciences, Rasht, Iran.

S H KoohmanaeiPediatric Growth Disorders Research Center, 17 Shahrivar Hospital, Guilan University of Medical Sciences, Rasht, Iran. ; Pediatric Endocrinologist, Guilan University of Medical Sciences, Rasht, Iran.

A Hassanzadeh RadPediatric Growth Disorders Research Center, 17 Shahrivar Hospital, Guilan University of Medical Sciences, Rasht, Iran.

S DaliliPediatric Growth Disorders Research Center, 17 Shahrivar Hospital, Guilan University of Medical Sciences, Rasht, Iran. ; Pediatric Endocrinologist, Guilan University of Medical Sciences, Rasht, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aim to determine the association between height and cancer in the children aged 14 years at the time of diagnosis in Rasht, Iran. MATERIALS AND

methodsIn this cross-sectional study, height of patients with a malignancy (≤14) at the time of diagnosis measured in the standard charts of United States National Center for the Health Statistics (NCHS). Data were reported by descriptive statistics and analyzed by Regression tests in SPSS version 19.

resultsOverall, 78 male (38.6%) and 124 female (61.4%) patients with various kinds of malignancies were evaluated for their heights. Leukemia was the most common type of cancer. The median height of the patients was more than 20(th) percentile and under 50(th) percentile of the NCHS. No significant association was found between height and leukemia.

conclusionPreviously, the median height of Iranian girls and boys (≤15) reported under 20(th) percentile of the NCHS. In this study, the median height of the patients at the time of diagnosis was more than 20(th) percentile of the NCHS. There was a correlation between height and cancer among our patients, although, this correlation can be assessed by further cohort study.

Indexed as

HeightMalignancyNCHSPediatricPercentile

Identifiers

PMID26131344

PMCPMC4475626

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.